What You Should Know:
4medica®, a healthcare data quality and matching technology company, today announced that the 4medica Enterprise Master Patient Index (EMPI) platform is now available on Google Cloud Marketplace.Built on Google Cloud’s Healthcare API, 4medica’s EMPI offers healthcare organizations access to a highly scalable data management services such as referential matching and identity enrichment.
Impact of Poor Healthcare Data Quality
Far
Read More
AI
AI in Healthcare| AI Impact for Researchers, Clinicians| Policy, News, Analysis, Insights - HIT Consultant
Ocutrx Acquires Spectrum AMT to Advance Capabilities for Medical Devices
What You Should Know:
Ocutrx Technologies, a global technology company developing medical devices with augmented reality (AR), extended reality (XR) and artificial intelligence (AI), acquires Spectrum Advanced Manufacturing Technologies, Inc., a Colorado-based electronics manufacturing and assembly company.With this acquisition, the consolidated Oxutrx_Spectrum company now has seven (7) process lines, including ISO Optics Lab capabilities,
Read More
Thinking Beyond CRM to Reach Healthcare Consumers
A new type of purpose-built technology is necessary to manage patient relationships.
Customer relationship management (CRM) systems are commonplace in nearly every industry, though their use in healthcare is complicated. Healthcare is incredibly complex and unique in many ways, and many generic CRM or CRM-like solutions address only one or two elements of the patient journey, such as appointment scheduling and reminders, without factoring in personal needs and preferences, health histories,
Read More
Availity Acquires Olive AI’s Utilization Management Solution and Business Unit
What You Should Know:
- Availity today announced a definitive agreement to acquire the utilization management solution and business unit from healthcare automation company Olive AI, Inc. Financial details of the acquisition were not disclosed.
- The acquisition of Olive AI's utilization management solution offers numerous benefits for Availity’s national network of payers and providers. These include lower administrative and medical costs, improved patient access
Read More
FDA & Cerner Enviza Collaborate to Develop AI Tools for Drug Safety
What You Should Know:
- Cerner Enviza, an Oracle company, and FDA’s Sentinel Innovation Center are teaming up to develop AI tools to extract and assess clinical notes to better understand drug safety.
- Teaming with John Snow Labs, Cerner Enviza will use AI and NLP to develop tools to extract information from clinical notes within the EHR to better aid in better understanding the effects of medicines on large populations. The project known as the Multi-source Observational
Read More
Clearday and Viveon Health Merge to Create Longevity Care Company
What You Should Know:
- Clearday, an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, and Viveon Health Acquisition Corp., a special purpose acquisition (SPAC) company have entered into a definitive merger agreement.
- The combined company's pro forma equity valuation (assuming no share redemptions) is expected to be approximately $370M. VHAQ currently has $20M held in a trust
Read More
The Future of Digital Transformation in Hospitals
Hospitals are increasingly motivated to drive digital transformation in order to improve patient outcomes, reduce costs, meet regulatory requirements and stay competitive. Additionally, digital transformation can support medical research and drive innovation in healthcare, as well as generate new revenue streams. An increasingly important tool as hospitals undergo these transformations is federated learning, a technology that we will expand on later. Federated learning is a machine learning
Read More
HeartFlow Raises $215M for AI-Powered Cardiac Test
What You Should Know:
- HeartFlow, Inc., a provider of precision heart care raises $215M in Series F funding round led by Bain Capital Life Sciences with participation from new investor Janus Henderson Investors, and existing investors including Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, USVP and Wellington Management.
- HeartFlow’s non-invasive personalized cardiac test provides unprecedented visualization of each patient’s coronary
Read More
PsychoGenics Launches AI Platform to Revolutionize Drug Discovery
What You Should Know:
- PsychoGenics Inc., a provider of AI-enabled phenotypic drug discovery and preclinical CRO services launches eCube®, a novel pharmaco-electroencephalography (“pharmacoEEG”) platform.
The platform supports phenotypic drug discovery, which unlike traditional target-based drug discovery, can identify novel treatments with multiple targets.
How eCube Works
eCube measures drug-induced changes to EEG spectra data and utilizes machine learning classifiers trained
Read More
How AI is Transforming Rare Disease Diagnosis
Collectively rare diseases are anything but rare – they impact 30 million people in the US and ten times that amount globally. And 1 in 3 children suffering from a rare disease will not survive beyond the age of five.
One of the biggest challenges facing clinicians is making a quick, accurate diagnosis – on average patients visit eight physicians and receive two to three misdiagnoses before being correctly diagnosed, a process that takes US patients around 7.6 years, and is often referred to
Read More
